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Interferon-b induction occurs during acute simian immunodeﬁciency virus (SIV) infection in the brain. We
have examined expression and function of cytosolic RNA sensors, retinoic acid inducible gene I (RIG-I), and
melanoma differentiation-associated protein 5 (MDA5), in vivo in the brain of our consistent, accelerated SIV-
macaque model and in vitro in SIV-infected macaque macrophages to identify the pathway of type I interferon
(IFN) induction. MDA5 messenger RNA (mRNA) and protein were expressed at higher levels in the brain than
RIG-I, with protein expression correlating with the severity of disease from 42 until 84 days post-inoculation.
The siRNA experiments reveal that mRNA expression of IFN-inducible gene MxA is dependent on MDA5, but
not RIG-I. Finally, we demonstrate that SIV infection leads to the production of double-stranded RNA in vivo,
which may act as the MDA5 ligand. We have shown for the ﬁrst time to our knowledge the functional role of
MDA5 in the innate immune response to SIV infection.
Although human immunodeﬁciency virus (HIV) and
simian immunodeﬁciency virus (SIV) cross the blood-
brain barrier and establish central nervous system
(CNS) infection early during acute infection, HIV-
associated neurological complications usually only oc-
cur during late stage disease [1–5]. This delay between
CNS infection and disease is partly due to the antiviral
effects of type I interferon (IFN) b, a hallmark of virus
infection [6–8]. Our consistent, accelerated SIV ma-
caque model of HIV-associated neurological disease
has been important in elucidating the role of viral and
host factors in the pathogenesis of HIV infection in the
CNS [9–14]. We have characterized the early infection
of the CNS and demonstrated that the brain is infected
by 4 days postinfection and shown that innate immune
responses, particularly IFN-b and the type I IFN in-
ducible gene MxA, are induced at this time in macro-
phages and microglial cells [10]. We have previously
demonstrated that control of virus replication in mac-
rophages and in brain is due, in part, to the induction of
the IFN-b–induced dominant-negative isoform of the
cellular transcription factor CCAAT/enhancer-binding
protein beta (C/EBPb). This isoform of C/EBPb down-
regulates the transcription of SIV and HIV in macro-
phages in vitro, and in the brain and lungs of SIV-infected
macaques in vivo [4, 15]. The pathway that is responsible
for the induction of IFN-b by either SIV or HIV in
macrophages or in the brain has not been identiﬁed.
The 2 major pathways for virus detection in the
cell are differentiated mainly by subcellular localization
of the receptorsdendosomal Toll-like receptors (TLRs)
or cytosolic RNA sensorsdboth of which trigger down-
stream innate immune responses. RIG-I and MDA5
are cytosolic RNA helicases that bind to ssRNA with
5#-triphosphates (RIG-I) or dsRNA (RIG-I and MDA5)
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19]. The 5#-triphosphates, a signature product of viral poly-
merase, and dsRNA are both non-self ligands, and the presence
of either molecule is an indicator of ongoing viral infection.
RIG-I and MDA5 signal through a mitochondria-bound
adapter protein, IFN-b promoter stimulator 1 (IPS-1), ulti-
mately activating an IRF-3-dependent type I IFN expression
[20]. IFN in turn induces the expression of increased levels of
RIG-I and MDA5 in a positive feedback loop. Although both
RIG-I and MDA5 are IFN-stimulated genes (ISGs), some vi-
ruses are known to employ unique mechanisms to antagonize
innate immune cellular defenses [21]. The roles of RIG-I and
MDA5 in the context of SIV infection have not yet been in-
vestigated using infection experiments in naturally permissive
cells such as macrophages.
Using our SIV macaque model of AIDS and HIV encephalitis,
we examined expression of RIG-I and MDA5 mRNAs and
proteins and report for the ﬁrst time the induction of RIG-I and
MDA5 mRNA and protein with different expression patterns in
the brains of SIV-infected macaques. Additionally, gene silenc-
ing experiments using siRNA in SIV-infected macaque macro-
phages demonstrated that MDA5, but not RIG-I, contributed to
the induction of IFN-b together with the endosomal TLR
pathway.
MATERIALS AND METHODS
Animal Experiments and Viruses
Fifty-three pigtailed macaques (Macaca nemestrina)w e r ei n -
travenously inoculated with SIV/DeltaB670 (50AID50) and SIV/
17E-Fr (10000 AID50) and sacriﬁced at 4, 7, 10, 14, 21, 42, 56,
and 84 days postinoculation as described elsewhere [12]. Pro-
cedural controls were sacriﬁced at 84 days post–mock in-
oculation.Manyoftheseanimalshavebeenincludedinprevious
publications [10, 22]. All animal protocols in this study were
approved by the Johns Hopkins University Institutional Animal
Care and Use Committee in accordance with Animal Welfare
Actregulationsandthe USPHSPolicyonHumaneCareandUse
of Laboratory Animals.
Histopathology
Sections of CNS tissue were examined in a blinded fashion by
microscope and the degree of encephalitis severity scored using
a semiquantitative system as described elsewhere [11].
Antibodies
Antibodies to RIG-I (Alexis Biochemicals), MDA5 (Alexis
Biochemicals), CD68 (DAKO), glial ﬁbrillary acidic protein
(GFAP) (DAKO), b3-tubulin (Promega), b-actin (Sigma),
and SIV mac251 gp41 (NIH AIDS Research and Reference
Reagent Program) were used. Double-stranded RNA-speciﬁc
monoclonal antibody J2 (English & Scientiﬁc Consulting)
recognizes the A-helix structure of dsRNA molecules at least
40bp long in a non–sequence-speciﬁc manner and do not
crossreact with ssRNA, tRNA, rRNA, mRNA, or RNA-DNA
hybrids [23].
Immunohistochemical Analysis
Parafﬁn-embedded tissue sections ofmacaquebasalganglia were
processed, probed, photographed, and analyzed as described
elsewhere [11]. For ﬂuorescent images, iVision (BioVision
Technologies) software was used.
Cell Culture
Blood from adult pigtailed macaques was processed using a Per-
coll gradient protocol, and PBMCs were maintained in RPMI
1640 (Invitrogen) supplemented with 20% (non-autologous)
pigtail serum, 200ng/mL M-CSF (R&D Systems), 10 mmol/L
HEPES (Invitrogen), 2 mmol/L L-glutamine (Invitrogen), and
0.5 mg/mL gentamicin (Invitrogen) (MDM20) for 7 days until
differentiation into monocyte-derived macrophages (MDM).
Thereafter, cells were maintained in RPMI with 10% pigtail
serum (MDM10).
Gene Silencing of RIG-I and MDA5
Cells were treated with 100 nmol/L of RIG-I–speciﬁc (5#-CU-
GAAUAUACUGCACCUCUTT-3#), MDA5-specifc (5#-UAU-
CAUUCGAAUUGUGUCATT-3#), or a nonspeciﬁc siRNA
control (5#-UUCUCCGAACGUGUCACGUTT-3#) (Integrated
DNA Technologies) using Hiperfect Transfection Reagent
(Qiagen) according to the manufacturer’s protocol. Cells were
transfected 24 hours prior to infection. Uridines had 2#-O-
methyl modiﬁcations to minimize induction of IFN and ISGs as
ar e s u l to ft r a n s f e c t i o n[ 24].
Chloroquine Treatment
Primary macaque macrophages were pretreated with 50 umol/L
ofthe endocytosis inhibitorchloroquine(Invivogen)30minutes
before infection. Cells were maintained in the presence of
chloroquine throughout the experiment until the indicated time
points.
SIV Infection of Primary Macrophages
Mock- or siRNA-transfected primary macrophages were in-
fected with SIV/17EFr [25] at a multiplicity of infection of 0.05
for 6 hours at 37C. After infection, cells were washed 5 times
with phosphate-buffered saline (PBS) and cultured in MDM10
until collection of samples at various time points.
RNA Extraction and qRT-PCR Analysis
Total RNA from basal ganglia tissue, as well as infected and/or
transfected cells was extracted, puriﬁed, and run in quantitative
reverse-transcriptase polymerase chain reaction (qRT-PCR)
conditions as described elsewhere [10]. Specifc primer and
probe sets to RIG-I (Fwd:5#-GTGCAAAGCCTTGGCATGT-3#,
RIG-I and MDA5 in SIV Infection d JID 2011:204 (1 October) d 1105Rev:5#-TGGCTTGGGATGTGGTCTACTC-3#,P r o b e : 5 #-AGAG
GAATGCCATTACACTGTGCTTGG-3#), MDA5 (Fwd:5#-GTT
TGGCAGAAGGAAGTGTC-3#,R e v : 5 #-GCTCTTGCTGCCA-
CATTCTC-3#, Probe:5#-AACAGCAACATGGGCAGTGATTC
AGG-3#), MxA (Fwd:5#-AGGAGTTGCCCTTCCCAGA-3#,
Rev:5#-TCGTTCACAAGTTTCTTCAGTTTCA-3#,P r o b e : 5 #-
ACCAGCGGGCATCTGGTCACGA-3#, 18S (Fwd:5#-AGTCCC
TGCCCTTTGTACACA-3#,R e v : 5 #-GATCCGAGGGCCTCAC-
TAAAC-3#,P r o b e : 5 #-CGCCCGTCGCTACTACCGATTGG-
3#), and SIV RNA (Fwd:5#-GTCTGCGTCATCTGGTGCAT
TC-3#,R e v : 5 #-CACTAGGTG TCTCTGCACTATCTGTTTTG-
3#,P r o b e : 5 #-CTTCCTCAGTGTGTTTCACTTTCTCTTCTG-
3#) were used. Fold-change calculations were performed using
the DDCt method, which involved an initial normalization
against an internal gene (18S ribosomal RNA), and a second
normalization against RIG-I/MDA5 expression in uninfected
control animals [26].
Protein Isolation and Western Blot Analysis
Cells were lysed with ice-cold radioimmunoprecipitation assay
buffer containing Protease Inhibitor Cocktail III (Calbiochem)
as described elsewhere [27]. Forty micrograms of protein was
resolvedusing a 10% polyacrylamide gel andprobedwithRIG-I,
MDA5, and b-actin antibodies.
Statistical Analysis
Spearman#s rank correlation test was used to determine corre-
lations of RIG-I and MDA5 mRNA and protein levels with the
largely previously published levels of SIV RNA, IFN-b mRNA,
and MxA mRNA as shown in Supplemental Figure 1 [10].
Mann–Whitney test was used to determine statistical differences
between 2 different time points and 2 different severity groups in
macaque brain samples. A 2-sample T test with equal variances
wasusedtoanalyzesigniﬁcancebetweensiRNA-orchloroquine-
treated cells versus untreated samples in vitro.
RESULTS
RIG-I and MDA5 mRNA Are Induced in the Brain During SIV
Infection
We examined the expression of RIG-I and MDA5 mRNA in the
brains of SIV-infected macaques at different stages of infection
by quantitative real time RT-PCR. Values were reported as fold-
change in RNA. At 4 days postinfection, both RIG-I and MDA5
mRNA expression levels increased in the SIV-infected brain.
RIG-I levels increased 4.2-fold, while MDA5 levels increased
20.7-fold (Figure 1A and B). MDA5 reached its highest level at 4
days postinfection, in contrast to RIG-I which peaked at 7 days
postinfection, with a 5.4-fold increase versus control. At 7 days
postinfection the increase in MDA5 was only 13.3-fold com-
pared with the peak of 20.7-fold at 4 days postinfection. By
10 days postinfection, both RIG-I and MDA5 mRNA expression
were dramatically reduced to levels comparable to those in
uninfected control. During acute infection (4–21 days post-
infection), both RIG-I and MDA5 expression negatively corre-
lated with SIV RNA, and positively correlated with IFN-b and
MxA mRNA (Table 1; Supplementary Table S1).
From 21 to 42 days postinfection, RIG-I and MDA5 con-
tinued to increase with the highest levels of expression of both
RIG-I and MDA5 at 42 days postinfection. The level of ex-
pression of both reﬂected the severity of CNS disease, with
macaques exhibiting moderate/severe disease having higher
fold-change gene induction (median expression: RIG-I512.5;
MDA5523.5) compared with macaques with none/mild dis-
ease (median expression: RIG-I56.2; MDA557.1). A signiﬁ-
cant difference between the medians of both severity groups
(moderate/severe vs. none/mild) was observed on 42 days
postinfection for MDA5 but not RIG-I (P 5 .0476 and
P 5 .3810, respectively). Levels for the moderate/severe ani-
mals stabilize from 42 to 84 days postinfection, while RIG-I
and MDA5 mRNA expression in the none/mild group dra-
matically decrease to levels comparable to uninfected control
animals at 56 days postinfection and maintains those levels
until 84 days postinfection. During the late stage of infection
(42–84 days postinfection), RIG-I and MDA5 correlated with
brain SIV RNA, IFN-b m R N A ,a n dM x Am R N A( Table 1;
Supplementary Table S1). It should be noted that during the
later stages of infection, IFN-b levels do not strongly parallel
MxA levels (Supplementary Table S1). Speciﬁcally, IFN-b
levels between none/mild versus moderate/severe groups be-
come quite close (56 and 84 days postinfection dpi), while
ISGs such as MxA, RIG-I, and MDA5 are 10-fold different
between these 2 severity groups (Supplementary Table S1).
This discrepancy is likely due to the brain switching to IFNa
(instead of IFN-b) production during the later stages of
infection [22].
RIG-I and MDA5 Protein Expression Are Differentially Regulated
in the Brain of SIV-Infected Macaques
In order to examine the location and temporal pattern of RIG-I
(Figure 1C, E,a n dG) and MDA5 expression (Figure 1D, F,a n d
H), immunohistochemical analysis was performed and protein
expressionwasquantitatedinbasal ganglia ofuninfectedcontrol
and SIV-infected macaques from 4 to 84 days postinfection.
Increased expression of RIG-I and MDA5 proteins were found
in white matter of infected macaques compared with uninfected
controls (Figure 1C and D). However, the increases in RIG-I
expression were much less signiﬁcant compared with MDA5
(Figure 1G and H). In contrast, gray matter had higher basal
levels of expression of both proteins, but there was little change
in expression of either protein during SIV infection (Figure 1E
and F). In the white matter, there was a modest 1.7-fold increase
in RIG-I protein expression at 7 days postinfection compared
with controls, and returned to uninfected levels at 10 and
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Figure 1. Relative induction of retinoic acid inducible gene I (RIG-I) and melanoma differentiation-associated protein 5 (MDA5) mRNA and protein in
brain of simian immunodeficiency virus (SIV)-infected macaques. A, RIG-I and (B) MDA5 mRNAwere measured by quantitative RT-PCR from basal ganglia
sections of uninfected and SIV-infected macaques sacrificed at various time points (4, 7, 10, 14, 21, 42, 56, or 84 days post inoculation). The number of
animals used for each time point are: 6 (4 days), 5 (7 days), 6 (10 days), 6 (14 days), 6 (21 days), 9 (42 days), 9 (56 days), 6 (84 days). The mRNA levels are
represented as fold-change over the average of 3 uninfected brain RNAs, calculated using the DDCt method. Medians (black bars) are indicated for each
experimental group. Each circle represents one animal, color-coded according to severity of CNS disease (red, moderate/severe; black, none/mild). The
RIG-I and MDA5 in SIV Infection d JID 2011:204 (1 October) d 110721 days postinfection (Figure 1C). In comparison, median
MDA5 expression was up-regulated by 13.2-fold at 4 days
postinfection, reaching a peak of 21-fold induction by 7 days
postinfection, before adjusting to 9.5-fold by 10 days post-
infection (Figure 1H). This pattern of MDA5 expression paral-
lels the expression of IFN-b and MxA mRNA in the brain of
these macaques peaking at 7 days postinfection, followed by
decreased expression by 10 days postinfection [10]. SIV RNA
expression in brain also increases from 4 to 7 days postinfection,
followed by decline from 10 to 14 days postinfection [10]. The
control of exponential virus replication at 10 and 14 days
postinfection is in part due to the expression of IFN-b and ISGs
in the brain during acute infection [10]. A negative correlation
was observed between MDA5 (but not RIG-I) protein expres-
sion in the white matter during acute stages of infection (4–21
days postinfection) and SIV RNA (r 52 0.4860; P 5 .0102).
A bifurcating pattern of expression for MDA5 at 42, 56, and
84 days postinfection was observed (Figure 1H). SIV-infected
macaques with moderate to severe encephalitis had higher me-
dian levels of MDA5 protein compared with none to mild disease
in macaque brain at 42, 56, and 84 days postinfection There is
a statistically signiﬁcant difference between medians of both se-
verity groups (moderate/severe vs none/mild) at 56 days post-
infection (P 5 .0238). The bifurcating pattern is markedly less
distinct forRIG-I protein expression, as is the overall inductionof
RIG-I (Figure 1G) .M D A 5p r o t e i ne x p r e s s i o ni nt h ew h i t em a t t e r
strongly correlated with SIV RNA and MxA mRNA (r 5 0.7426,
P , .0001 and r 5 0.7704, P , .0001, respectively), but not IFN-
b (r 5 0.1861,P 5 .384). There were no correlations between the
expression of RIG-I protein with SIV RNA, IFN-ß mRNA, or
MxA mRNA.
RIG-I and MDA5 Protein Is Induced in Perivascular
Macrophages and Astrocytes of SIV-Infected Macaques
In order to determine the speciﬁc cells in the brain that ex-
pressed RIG-I and MDA5 proteins, immunohistochemistry us-
ing ﬂuorescent probes was done on uninfected and SIV-infected
brain (basal ganglia) from 10 days postinfection. We demon-
strated that in uninfected brain, protein expression for both
RIG-I (Figure 2A) and MDA5 (Figure 2B) was undetectable in
perivasular macrophages and astrocytes, while being constitu-
tively expressed in neurons. In contrast, in SIV-infected brain,
protein levelsfor both RIG-I (Figure3A) and MDA5(Figure3B)
were clearly induced in perivascular macrophages and as-
trocytes. Expression of both proteins was maintained in neurons
of infected animals.
SIV-Infection Produces Double-Stranded RNA in Brain
Macrophages
We examined whether there was double-stranded RNA
(dsRNA) in the brain of SIV-infected macaques by performing
immunohistochemistry using an antibody capable of recogniz-
ing dsRNA helices longer than 40bp [28]. The dsRNA was de-
tected in SIV-infected brain in perivascular macrophages and
colocalized with detection of SIV gp41 protein in the same cell
(Figure 4B). There was no dsRNA detected in the brain of un-
infected animals (Figure 4A). This provides evidence that
dsRNA is produced in SIV-infected macrophages in brain and
can be recognized by either RIG-I or MDA5.
SIV Infection Induces MDA5-Dependent, but Not RIG-I–
Dependent, Type I IFN Response in Macrophages
In order to determine whether RIG-I or MDA5 (or both) played
a role in inducing the type I IFN response to SIV infection,
primary pigtail macaque macrophages were used and RIG-I and
MDA5 silenced using small interfering RNA (siRNA). Macro-
phages were transfected with either a scrambled siRNA control,
or a gene-speciﬁc RIG-I- and MDA5-siRNA, in at least 3 in-
dependent experiments. The levels of both proteins were ana-
lyzed at 24 and 48 hours postinfection; and while protein levels
decreased at 24hours,there was no signiﬁcant effect onfunction
until 48 hours. The reduction of RIG-I protein was 40% at
48 hours postinfection in this experiment (Figure 5A), but
medians for both moderate/severe (red dashed line) and none/mild (black dashed line) animals are represented in the 42-, 56-, and 84-day groups. For
protein expression, basal ganglia tissue sections from SIV-infected macaque brains were singly probed using either RIG-I or MDA5-specific antibodies
and stained with liquid diaminobenzidine (DAB) and digitally quantified. Protein expression of RIG-I in white (C) and gray matter (E), as well as MDA5 in
white (D) and gray matter (F) was quantified using measured area. These results are represented as median fold-change for RIG-I (G) and MDA5 (H), with
white matter (circles) and gray matter (triangles) color-coded according to severity of CNS disease (red, moderate/severe; black, none/mild).
Table 1. Correlation of RIG-I and MDA5 mRNA With SIV RNA,
IFN-b, and MxA mRNA.
Acute stage
RIG-i MDA5
r
a P
b rP
SIV RNA 20.3539 .0597 20.4974 .0061
IFN-b mRNA 0.444 .0158 0.4398 .017
MxA mRNA 0.8131 ,.0001 0.8166 ,.0001
Terminal stage
SIV RNA 0.6271 .001 0.7964 ,.0001
IFN-b mRNA 0.4063 .0488 0.4097 .0468
MxA mRNA 0.7145 ,.0001 0.8317 ,.0001
a Correlation coefﬁcient.
b Signiﬁcance.
1108 d JID 2011:204 (1 October) d Co et alFigure 2. Retinoic acid inducible gene I (RIG-I) and melanoma differentiation-associated protein 5 (MDA5) expression in specific brain cells in
uninfected macaques. RIG-I (A) and MDA5 (B) protein expression were investigated in uninfected basal ganglia brain tissue sections by dual staining with
specific brain markers for macrophages (CD68), astrocytes (glial fibrillary acidic protein [GFAP]), and neurons (ß3-tubulin), as well as RIG-I and MDA5
specific antibodies. Fluorescent secondary antibodies were used and overlays analyzed using a fluoresent microscope. It is shown that RIG-I and MDA5
are both hardly expressed in perivascular macrophages and astrocytes, while being constitutively expressed in neurons.
RIG-I and MDA5 in SIV Infection d JID 2011:204 (1 October) d 1109knockdown ranged from 40% to 70% in experimental repli-
cates. On the other hand, MDA5 protein was reduced by 74%
at 48 hours post infection (Figure 5B). Type I IFN induction,
which was measured using the induction of the ISG MxA
mRNA, was signiﬁcantly reduced by 14.7-fold in MDA5 siRNA-
treated cells at 48 hours postinfection (P 5 .0035) compared
with controls (Figure 5D). Despite the variable 40%–70% re-
ductioninRIG-I,MxAlevelsneverdecreasedin the experiments
Figure 3. Retinoic acid inducible gene I (RIG-I) and melanoma differentiation-associated protein 5 (MDA5) expression in specific brain cells in SIV-
infected macaques. RIG-I (A) and MDA5 (B) protein expression were investigated in infected basal ganglia brain tissue sections by dual staining with
specific brain markers for macrophages (CD68), astrocytes (glial fibrillary acidic protein {GFAP}), and neurons (ß3-tubulin), as well as RIG-I and MDA5
specific antibodies. Fluorescent secondary antibodies were used and overlays analyzed using a fluoresent microscope as described in Materials and
Methods. White arrowheads indicate colocalization of RIG-I and CD68, and RIG-I and GFAP in (A), and MDA5 and GFAP in (B). It is shown that RIG-I and
MDA5 are both induced in perivascular macrophages and astrocytes upon infection, while being constitutively expressed in neurons.
1110 d JID 2011:204 (1 October) d Co et albut surprisingly increased (P 5 .0136) (Figure 5C). Thus, the
intracellular signaling induced by SIV infection of macrophages
that leads to type I IFN response and ISGs appears to be MDA5-
dependent.
Induction of the Type I IFN Response in SIV-Infected
Macrophages Is Not Exclusively Through Cytosolic Sensors
In order to determine whether type I IFN response also signaled
through endocytosis-dependent pathways such as the TLR
response, macrophages were pretreated with chloroquine
30 minutes before infection. MxA was downregulated in
SIV-infected, chloroquine treated cells by 5.1-fold at 48 hours
(P 5 .0077) compared with untreated, infected cells (Figure 5E).
When cells were pretreated with both MDA5 siRNA and
chloroquine, MxA expression was down-regulated by 12.4-fold
(P 5 .0027), compared with controls (Figure 5F). These data
suggest that intracellular signaling induced by SIV infection of
macrophagesthatleadstothetypeIIFNresponseoccursthrough
both MDA-5 and the endocytosis-dependent TLR pathway.
DISCUSSION
The innate immune response to SIV infection in the CNS is
critical for controlling viral replication during acute infection
and preserving the neurological function within the immune-
privileged site of the brain. We have previously shown co-
ordinated regulation of innate immune responses, including
IFN-b and MxA, which function to control viral replication
during the early stages of infection in SIV-infected macaque
brains [10]. In this study, we examine the pathways in macaque
brain and in primary macrophages that induce IFN-b.
We demonstrate for the ﬁrst time to our knowledge that both
cytosolic RNA sensors RIG-I and MDA5 are signiﬁcantly in-
ducedinthebrainsofSIV-infectedmacaquesatthemRNAlevel.
Although both RIG-I and MDA5 proteins increase upon SIV
infection, only MDA5 upregulation was statistically signiﬁcant.
TheincreasedexpressionofRIG-IandMDA5proteinwasfound
in astrocytes and perivascular macrophages, while constitutive
expression was observed in neurons. Additionally, SIV-infected
macrophages induce the type I IFN response in an MDA5-, but
not a RIG-I-dependent manner. Finally, we demonstrate that
signaling in response to SIV is not exclusively through the cy-
tosolic sensors, as treatment with chloroquine also decreased the
levels of the ISG MxA, implicating a role for membrane-bound
TLR sensors as well.
Unlike other RNA viruses that use viral polymerase to syn-
thesize their genome in the cytosol, HIV and SIV exclusively use
the cellular transcriptional machinery in the nucleus. Corre-
spondingly, the newly synthesized viral genome is also subject to
posttranscriptional modiﬁcations. This results in masking of the
5#-triphosphate, the ligand of RIG-I in the viral genome, by
a methylated guanosine cap similar to cellular mRNA, resulting
in the viral RNA appearing to be ‘‘self’’ RNA [29]. In addition to
the absence of a 5#-triphosphate, retroviruses do not possess
a dsRNA intermediate step in their replication cycles. However,
the HIV genome does form complex secondary structures that
result in long stretches of dsRNA, the ligand for MDA5 [30–35].
In fact, the architecture and extensive secondary structure of an
entire HIV-1 RNA genome was demonstrated using high-
throughput RNA analysis [36]. These secondary structures
constitute previously unrecognized regulatory motifs and are an
important and conserved part of the genetic code. In this respect,
the HIV genome with its long stretches of dsRNA regions could
trigger MDA5. We have found that SIV infection in brain leads
to signiﬁcant amounts of .40bp long dsRNA molecules, par-
ticularly in perivascular macrophages, the main site of SIV in-
fection. In contrast, dsRNA was not detected in astrocytes,
probably because SIV replication is restricted in these cells in
vivo [37]. In vitro, MxA expression is reduced in SIV-infected
macrophages that have signiﬁcantly reduced expression of
MDA5 protein. This effect is not seen when RIG-I expression is
reduced. The lack of a 5#-triphosphate ‘‘viral signature’’ in ret-
roviruses alsosuggeststhat the cytosolic sensorRIG-Iisnot used
for antiretroviral IFN-b induction.
Introduction of RNA molecules to silence genes in in vitro
experiments causes unwanted stimulation of the type I IFN re-
sponse [38]. Optimization of gene silencing experiments was
Figure 4. Double-stranded RNA (dsRNA) is detected in simian
immunodeficiency virus (SIV)–infected perivascular macrophages. Un-
infected (A) and SIV-infected (B) basal ganglia tissue sections from
macaques were dual probed with antibodies against SIV gp41 and dsRNA
and stained using vector red and liquid diaminobenzidine (DAB),
respectively. Colocalization of SIV gp41 protein and dsRNA in infected
perivascular macrophages indicates that SIV infection produces detect-
able amounts of dsRNA.
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of the cytosolic sensors resulted in upregulation of ISGs and was
a challenge for our studies. To minimize this effect, siRNAs with
uridine 2#-O-methyl modiﬁcations were used because these
modiﬁcations enable binding of the siRNA to RIG-I–like
receptors and TLR7/8, but do not trigger downstream signaling
or interfere with silencing efﬁciency [24, 39].
The protective antiviral effects of type I IFN have been
demonstrated during acute SIV infection [4, 5, 27], whereas IFN
expression during the later stages of infection appears to con-
tribute to the increase in inﬂammatory cytokines and CNS
disease during chronic and late stages of HIV infection [40]. In
this study, MDA5 protein expression negatively correlated with
SIV RNA during the acute infection, suggesting that MDA5
expression negatively impacts SIV replication. Conversely,
MDA5 protein positively correlated with SIV RNA and MxA
mRNA during the terminal phase of infection, suggesting that
during later stages of disease, MDA5and MxA are associated with
the inﬂammatory environment that underscore the uncontrolled
innate immune responses in the brain.
It is interesting to speculate why RIG-I did not increase to the
same extent as MDA5 in response to IFN-b in the brain, since
both are considered ISGs and signal through the same adaptive
molecule, IPS-1. However, there are important differences
Figure 5. Type I interferon (IFN) stimulated gene MxA is induced in a melanoma differentiation-associated protein 5 (MDA5)- and Toll-like receptor
(TLR)–dependent manner. RIG-I (A) and MDA5 (B) were silenced with either a scrambled control sequence or gene-specific siRNA containing 2#-O-methyl
uridine modifications in order to prevent immune stimulation during transfection of macaque monocyte-derived macrophages. Knockdown efficiency was
evaluated at 48 hours post-infection using western blot by first normalizing protein levels against ß-actin and then comparing against Hiperfect-only
treated cells. MxA mRNA (C–F) was measured by quantitative RT-PCR from total RNA of monocyte-derived macrophages pretreated with (C) 100 nmol/L
RIG-I siRNA, (D) 100 nmol/L MDA5 siRNA, (E) 50 umol/L of chloroquine, or (F) both MDA5 siRNA and chloroquine, before SIV infection. The mRNA levels
are represented as fold-change over uninfected macrophage RNA and calculated using the DDCt method. Data are representative of at least 3
independent experiments. A 2-sample T test with equal variances was used to analyze significance between treatments.
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a more versatile pattern recognition receptor, recognizing viral
RNA as well as bacterial DNA [41, 42]. MDA5 appears to be
specialized for viral dsRNA detection. Thus, MDA5 may be
upregulated via pathways speciﬁc for viral infection. Further-
more, retroviral proteins could act to antagonize RIG-I in a di-
rect or indirect manner, as seen in other virus-cell interactions
[21].
TLR and cytosolic sensors may have a similar role in mac-
rophages as they do in plasmacytoid dendritic cells (pDCs). In
pDCs, TLR-dependentviral recognition and type I IFN feedback
signaling masks the requirement of viral replication for IFN-a
production; thus, cytosolic sensors are dispensable. However, if
the positive feedback loop is disabled, then IFN-a production in
pDCs becomes viral replication-dependent and signals through
the RIG-I/MDA5-IPS1 pathway [43]. In a similar manner, HIV-
infected macrophages probably signal through both TLR- and
cytosolic-sensing paths, depending on the extent of infection as
well as the strength of the primary IFN response. Since the IFN
response in pDCs is signiﬁcantly stronger than in macrophages,
it is possible that cytosolic sensors play a greater role in these
cells than their corresponding roles in pDCs. Unlike HIV in-
fection of T cells that occurs exclusively through direct fusion of
viral and cellular membranes, HIV infection in macrophages
occurs through both endocytosis and fusion [44, 45]. These
2 routes of HIV infection in macrophages further support a dual
method of viral detection: by the cytosolic sensor MDA5 and
membrane-bound TLRs.
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